Zynerba shares up in smoke after trial failure

06:10 EDT 7 Aug 2017 | BioPharmaDive

Shares in the biotech fell sharply after it announced negative topline results for its lead product in a clinical trial

Original Article: Zynerba shares up in smoke after trial failure


More From BioPortfolio on "Zynerba shares up in smoke after trial failure"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...